Moteur de recherche d’entreprises européennes
Financement de l’UE (8 370 157 €) : Systèmes de détection de biomarqueurs en temps réel pour une prise de décision médicale rapide dans le cancer et les maladies cardiaques Hor01/12/2023 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Systèmes de détection de biomarqueurs en temps réel pour une prise de décision médicale rapide dans le cancer et les maladies cardiaques
RealCare is a cutting-edge research initiative focused on developing and validating next-generation point-of-care (PoC) systems that detect essential biomarkers in human biofluids in real-time. These systems are designed to be compact, energy-efficient, and integrated with extended reality interfaces, with a specific emphasis on cancer and cardiac diseases in demanding clinical settings. RealCare's approach includes advanced biomarker detection technologies, such as microfluidics and new generations of microneedles, label-free electrochemical biosensors using 2D materials, optical sensors utilizing CRISPR, biological amplifiers combined with fluorescent microscopy, and scalable SPR with energy-efficient electronic readouts, AI data processing, and wireless communication units. Additionally, RealCare will design portable, interoperable, and adaptable PoC systems that integrate the biomarker detection technology with vital sign monitoring, including advanced data analytics and AI methods. The initiative also focuses on developing intuitive extended reality interfaces, such as augmented and virtual reality, to visualize biomarker data in real-time and facilitate rapid medical decision-making in integrated in-care environments and workflows. Rigorous clinical validation studies will be conducted in relevant clinical settings, including the surgery room, ICU, and patient's home, to ensure accuracy, reliability, usability, and impact on patient outcomes. RealCare places special attention on including a diverse patient population in their studies to validate the effectiveness of the developed systems. Data quality, interoperability, and medical data protection are key considerations in RealCare's strategy. Based on our unique PoC technological platform and our strong, multidisciplinary consortium partnership, we propose promising lab-to-market paths with the potential for significant societal impact.
| Ecole Polytechnique Federale DE Lausanne | ? |
| Charite - Universitaetsmedizin Berlin | 1 139 510 € |
| Commissariat a L Energie Atomique et aux Energies Alternatives | 1 635 691 € |
| DEN Institute | 560 000 € |
| E.P.O.S. Iasis Research and Development Ltd. | 547 619 € |
| Fondation Hopital Saint Joseph | 0,00 € |
| Institut Gustave Roussy | 1 472 890 € |
| Stichting Imec Nederland | 871 273 € |
| Universitatea Nationala de Stiintasi Tehnologie Politehnica Bucuresti | 482 500 € |
| Universiteit Twente | 1 660 675 € |
https://cordis.europa.eu/project/id/101137466
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Ecole Polytechnique Federale de Lausanne, Lausanne, Suisse.
